|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
EYE
|
Nova Eye Medical Limited
|
AU
|
ASX
|
|
OPT
|
Opthea Ltd
|
AU
|
ASX
|
|
BICTF
|
Biocure Technology Inc
|
US
|
OTC
|
|
CDXI
|
Cardax Inc
|
US
|
OTC
|
|
ELXMF
|
Nova Eye Medical Limited
|
US
|
OTC
|
|
GSGTF
|
Gensight Biologics Sa
|
US
|
OTC
|
|
MLLCF
|
Molecular Partners Ag
|
US
|
OTC
|
|
OXBDF
|
Oxford Biomedical Lt
|
US
|
OTC
|
|
SKYE
|
Skye Bioscience Inc
|
US
|
OTC
|
|
SNPHF
|
Santen Pharmaceutica
|
US
|
OTC
|
|
SNPHY
|
Santen Pharmaceutical Co
|
US
|
OTC
|
|
JNJ
|
Johnson & Johnson Co DRC
|
AR
|
BA
|
|
REG1V
|
Revenio Group Corporation
|
FI
|
HE
|
|
FYB
|
Formycon AG
|
DE
|
F
|
|
JNJ
|
Johnson & Johnson
|
DE
|
F
|
|
O2T
|
IVERIC bio Inc
|
DE
|
F
|